Getein Biotech, Inc (603387.SS)
CNY 8.59
(-0.12%)
CNY 8.59
(-0.12%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 616.5 Million CNY | 3.87% |
| 2022 | 630.41 Million CNY | 30.55% |
| 2021 | 482.91 Million CNY | 33.86% |
| 2020 | 360.75 Million CNY | 10.45% |
| 2019 | 326.63 Million CNY | 12.88% |
| 2018 | 289.35 Million CNY | 55.56% |
| 2017 | 186 Million CNY | 23.6% |
| 2016 | 150.49 Million CNY | 26.65% |
| 2015 | 118.82 Million CNY | 23.86% |
| 2014 | 95.93 Million CNY | 61.87% |
| 2013 | 59.26 Million CNY | 43.63% |
| 2012 | 41.26 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 130.84 Million CNY | -15.8% |
| 2024 Q1 | 129.58 Million CNY | -26.89% |
| 2024 Q2 | 141.29 Million CNY | 9.04% |
| 2023 FY | 654.81 Million CNY | 3.87% |
| 2023 Q3 | 165.04 Million CNY | -1.28% |
| 2023 Q4 | 177.25 Million CNY | 7.4% |
| 2023 Q1 | 145.33 Million CNY | -27.82% |
| 2023 Q2 | 167.18 Million CNY | 15.03% |
| 2022 Q1 | 139.38 Million CNY | -12.06% |
| 2022 FY | 630.41 Million CNY | 30.55% |
| 2022 Q3 | 138.04 Million CNY | -8.96% |
| 2022 Q2 | 151.63 Million CNY | 8.78% |
| 2022 Q4 | 201.35 Million CNY | 45.86% |
| 2021 Q3 | 110.97 Million CNY | -5.2% |
| 2021 Q2 | 117.05 Million CNY | 21.46% |
| 2021 FY | 482.91 Million CNY | 33.86% |
| 2021 Q1 | 96.37 Million CNY | -24.66% |
| 2021 Q4 | 158.5 Million CNY | 42.84% |
| 2020 Q2 | 87.22 Million CNY | 51.79% |
| 2020 Q4 | 127.91 Million CNY | 45.1% |
| 2020 FY | 360.75 Million CNY | 10.45% |
| 2020 Q1 | 57.46 Million CNY | -39.01% |
| 2020 Q3 | 88.15 Million CNY | 1.07% |
| 2019 Q2 | 83.91 Million CNY | 31.66% |
| 2019 Q4 | 94.21 Million CNY | 11.15% |
| 2019 FY | 326.63 Million CNY | 12.88% |
| 2019 Q3 | 84.76 Million CNY | 1.02% |
| 2019 Q1 | 63.73 Million CNY | -40.95% |
| 2018 Q1 | 49.35 Million CNY | -15.55% |
| 2018 FY | 289.35 Million CNY | 55.56% |
| 2018 Q4 | 107.93 Million CNY | 62.3% |
| 2018 Q3 | 66.5 Million CNY | 1.04% |
| 2018 Q2 | 65.81 Million CNY | 33.36% |
| 2017 Q1 | 31.9 Million CNY | -39.27% |
| 2017 Q2 | 47.51 Million CNY | 48.95% |
| 2017 Q3 | 48.14 Million CNY | 1.31% |
| 2017 Q4 | 58.44 Million CNY | 21.39% |
| 2017 FY | 186 Million CNY | 23.6% |
| 2016 Q3 | 32.7 Million CNY | 186.15% |
| 2016 Q1 | -25.35 Million CNY | 0.0% |
| 2016 Q2 | -37.96 Million CNY | -49.73% |
| 2016 Q4 | 52.53 Million CNY | 60.62% |
| 2016 FY | 150.49 Million CNY | 26.65% |
| 2015 Q1 | 23.23 Million CNY | 0.0% |
| 2015 FY | 118.82 Million CNY | 23.86% |
| 2014 FY | 95.93 Million CNY | 61.87% |
| 2013 FY | 59.26 Million CNY | 43.63% |
| 2012 FY | 41.26 Million CNY | 0.0% |